alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Subpart 927.2 - Patents

Source: 60 FR 11815, Mar. 2, 1995, unless otherwise noted.

Parent topic: PART 927 - PATENTS, DATA, AND COPYRIGHTS

927.200 Scope of subpart.

When consulting 48 CFR part 27, subpart 27.2 of the FAR, consider “research, development, and

demonstration” to replace the phrase “research and development” or “R&D,” for the purposes of

DOE actions.

927.201 Authorization and consent.

927.201-1 General.

In certain contracting situations, such as those involving research, development, or demonstration

projects, consideration should be given to the impact of third party-owned patents covering

technology that may be incorporated in the project which patents may ultimately affect widespread

commercial use of the project results. In such situations, Patent Counsel shall be consulted to

determine what modifications, if any, are to be made to the utilization of the Authorization and

Consent and Patent Indemnity provisions or what other action might be deemed appropriate.

927.206 Refund of royalties.

927.206-1 General.

The clause at 952.227-9, Refund of Royalties, obligates the contractor to inform DOE of the payment

of royalties pertaining to the use of intellectual property, either patent or data related, in the

performance of the contract. This information may result in identification of instances in which the

Government already has a license for itself or others acting in its behalf or the right to sublicense

others. Also, there may be pending antitrust actions or challenges to the validity of a patent or the

proprietary nature of the data, or the contractor may be able to gain unrestricted access to the same

data through other sources. In such situations the contractor may avoid the payment of a royalty in

its entirety or may be charged a reduced royalty.

927.206-2 Clause for refund of royalties.

The contracting officer shall insert the clause at 952.227-9, Refund of Royalties, in solicitations and

contracts for experimental, research, developmental, or demonstration work or other solicitations
and contracts in which the contracting officer believes royalties will have to be paid by the

contractor or a subcontractor of any tier.

927.207 Classified contracts.

927.207-1 General.

Unauthorized disclosure of classified subject matter, whether in a patent application or resulting

from the issuance of a patent, may be a violation of the Atomic Energy Act of 1954, as amended,

other laws relating to espionage and national security, and provisions of the proposed contract

pertaining to disclosure of information.
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. 3437 Introduced in Senate (IS)]

109th CONGRESS
  2d Session
                                S. 3437

   To suspend temporarily the duty on 1H-Imidazole-4,5-dimethanol, 2-
                             phenyl- (9Cl).

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              June 6, 2006

   Mr. Reid introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
   To suspend temporarily the duty on 1H-Imidazole-4,5-dimethanol, 2-
                             phenyl- (9Cl).

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 1H-IMIDAZOLE-4,5-DIMETHANOL, 2-PHENYL- (9CL).

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

      

``      9902.29.12        1H-Imidazole-4,5-       Free      No change       No change       On or before 12/
                           dimethanol, 2-phenyl-                                             31/2009          ''
                           (9Cl) (provided for                                                                 .
                           in subheading
                           2933.29.43) (CAS No.
                           61698-32-6)..........

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. 3157 Introduced in Senate (IS)]

109th CONGRESS
  2d Session
                                S. 3157

   To suspend temporarily the duty on MCPB acid and MCPB sodium salt.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 25, 2006

   Mr. Obama introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
   To suspend temporarily the duty on MCPB acid and MCPB sodium salt.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SUSPENSION OF DUTY ON MCPB ACID AND MCPB SODIUM SALT.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

      

``      9902.28.21        4-(4-chloro-2-          Free      No change       No change       On or before 12/
                           methylphenoxy)                                                    31/2009          ''
                           butanoic acid (CAS                                                                  .
                           No. 94-81-5); 4-(4-
                           chloro-2-
                           metylphenoxy)
                           butanoic acid, sodium
                           salt (CAS No. 6062-26-
                           6) (provided for in
                           subheading 2918-90-
                           20.).................

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
**EXHIBIT
      32.2**





**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the Quarterly Report of Centenary International Corporation
      (the
“Company”) on Form 10-QSB for the period ending June 30, 2007, as filed with the
      Securities and Exchange Commission on the date hereof (the “Report”), I, Hector
      A. Patron Costas, Chief Financial Officer of the Company, certify, pursuant
      to
      18 U.S.C. Sec. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
      Act of 2002, that, to the best of my knowledge and belief:





(1)  the
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





(2)  the
      information contained in the Report fairly presents, in all material respects,
      the financial condition and result of operations of the Company.




/s/
      Hector A. Patron Costas


Hector
      A.
      Patron Costas


Chief
      Financial Officer


August
      8,
      2007





A
      signed
      original of this written statement required by Section 906, or other document
      authenticating, acknowledging, or otherwise adopting the signature that appears
      in typed form within the electronic version of this written statement has been
      provided to the Company and will be retained by the Company and furnished to
      the
      Securities and Exchange Commission or its staff upon request. The foregoing
      certifications are accompanying the Company's Form 10-QSB solely pursuant to
      section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of
      section 1350, chapter 63 of title 18, United States Code) and are not being
      filed as part of the Form 10-QSB or as a separate disclosure
      document.
Case 2:06-cv-00667-WKW-WC Document 31 Filed 12/13/2006 Page 1 of 13
Case 2:06-cv-00667-WKW-WC Document 31 Filed 12/13/2006 Page 2 of 13
Case 2:06-cv-00667-WKW-WC Document 31 Filed 12/13/2006 Page 3 of 13
Case 2:06-cv-00667-WKW-WC Document 31 Filed 12/13/2006 Page 4 of 13
Case 2:06-cv-00667-WKW-WC Document 31 Filed 12/13/2006 Page 5 of 13
Case 2:06-cv-00667-WKW-WC Document 31 Filed 12/13/2006 Page 6 of 13
Case 2:06-cv-00667-WKW-WC Document 31 Filed 12/13/2006 Page 7 of 13
Case 2:06-cv-00667-WKW-WC Document 31 Filed 12/13/2006 Page 8 of 13
Case 2:06-cv-00667-WKW-WC Document 31 Filed 12/13/2006 Page 9 of 13
Case 2:06-cv-00667-WKW-WC Document 31 Filed 12/13/2006 Page 10 of 13
Case 2:06-cv-00667-WKW-WC Document 31 Filed 12/13/2006 Page 11 of 13
Case 2:06-cv-00667-WKW-WC Document 31 Filed 12/13/2006 Page 12 of 13
Case 2:06-cv-00667-WKW-WC Document 31 Filed 12/13/2006 Page 13 of 13
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                          457098
<SECURITIES>                                         0
<RECEIVABLES>                                     5557
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                462655
<PP&E>                                         4663466
<DEPRECIATION>                                 1231890
<TOTAL-ASSETS>                                 3431575
<CURRENT-LIABILITIES>                           486573
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                     3408500<F1>
<TOTAL-LIABILITY-AND-EQUITY>                   3895073
<SALES>                                              0
<TOTAL-REVENUES>                                552407
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                502220
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     20416
<EPS-PRIMARY>                                     2.31<F2>
<EPS-DILUTED>                                        0
<FN>
<F1>Refers to General Partners' and Limited Partners' Capital.
<F2>95% Limited Partners - Interests outstanding=20653.69.
</FN>
        

</TABLE>
**Exhibit 31.2**

 

**CERTIFICATION**

 

I, James W. Dolan, certifythat:

 

1. I have reviewed thisquarterly report on Form 10-Q of MAI Systems Corporation;

 

2. Based on my knowledge, thisquarterly report does not contain any untrue statement of a material fact or omitto state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading withrespect to the period covered by this quarterly report;

 

3. Based on my knowledge, thefinancial statements, and other financial information included in thisquarterly report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this quarterly report;

 

4. The registrant’s othercertifying officers and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and15d-14) for the registrant and we have:

 

a)              designed such disclosure controls andprocedures to ensure that material information relating to the registrant,including its consolidated subsidiaries, is made known to us by others withinthose entities, particularly during the period in which this quarterly reportis being prepared;

 

b)             evaluated the effectiveness of theregistrant’s disclosure controls and procedures as of a date within 90 daysprior to the filing date of this quarterly report (the “Evaluation Date”); and

 

c)              presented in this quarterly report ourconclusions about the effectiveness of the disclosure controls and proceduresbased on our evaluation as of the Evaluation Date;

 

5. The registrant’s othercertifying officers and I have disclosed, based on our most recent evaluation,to the registrant’s auditors and the audit committee of registrant’s board ofdirectors (or persons performing the equivalent function):

 

a)              all significant deficiencies in thedesign or operation of internal controls which could adversely affect theregistrant’s ability to record, process, summarize and report financial dataand have identified for the registrant’s auditors any material weaknesses ininternal controls; and

 

b)             any fraud, whether or not material, thatinvolves management or other employees who have a significant role in theregistrant’s internal controls; and

 

6. The registrant’s othercertifying officers and I have indicated in this quarterly report whether ornot there were significant changes in internal controls or in other factorsthat could significantly affect internal controls subsequent to the date of ourmost recent evaluation, including any corrective actions with regard tosignificant deficiencies and material weaknesses.

 

 
| Date: November 6, 2003 | By :   |   | /s/ James W. Dolan                     |
|------------------------|--------|--------|----------------------------------------|
|                   |   |   | James W.  Dolan                        |
|                   |   |   | Chief  Financial and Operating Officer |

 

1

----
435.010 Scientific and technical reports.

Research and development contracts shall contain a provision requiring that the contractor send

copies of all scientific and technical reports to the National Technical Information Service at the

address indicated in FAR 35.010(b). The release of research and development contract results to

other government activities and to the private sector is subject to the provisions of FAR subpart 4.4.

Parent topic: PART 435 - RESEARCH AND DEVELOPMENT CONTRACTING
II 

109TH CONGRESS 

2D SESSION S. 3371 

To suspend temporarily the duty on mixtures of difenoconazole/mefenoxam. 

IN THE SENATE OF THE UNITED STATES 

JUNE 5, 2006 

Mr. NELSON of Nebraska introduced the following bill; which was read twice 

and referred to the Committee on Finance 

A BILL 

To suspend temporarily the duty on mixtures of 

difenoconazole/mefenoxam. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. MIXTURES OF DIFENOCONAZOLE/MEFENOXAM. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading: 


cchase on PROD1PC60 with BILLS
2 

•S 3371 IS 

‘‘ 9902.12.53 Mixtures of 1H-1,2,4-triazole, 1-((2- 

chlorophenoxy)phenyl)–4- 

methyl-1,3-dioxolan-2- 

yl)methyl)- (Difenoconazole) 

(CAS No. 119446–68–3), 

(R,S)–2-((2,6- 

dimethylphenyl) 

methoxyacetylamino) propionic acid, methyl ester 

(Mefenoxam) (CAS Nos. 

70630–17–0, and 69516– 

34–3) and application adjuvants (provided for in subheading 3808.20.15) ............ Free No change No change On or before 

12/31/2009 ’’. 

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies to goods entered, or withdrawn from 

3 warehouse for consumption, on or after the 15th day after 

4 the date of the enactment of this Act. 

Æ 


cchase on PROD1PC60 with BILLS
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. 3368 Introduced in Senate (IS)]

109th CONGRESS
  2d Session
                                S. 3368

             To suspend temporarily the duty on Permethrin.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              June 5, 2006

 Mr. Nelson of Nebraska introduced the following bill; which was read 
             twice and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
             To suspend temporarily the duty on Permethrin.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PERMETHRIN.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``      9902.10.80       (3-                Free         No change        No change        On or before 12/  ''.
                         Phenoxyphenyl)met                                                  31/2009
                         hyl 3-(2,2-
                         dichloroethenyl)-
                         2,2-
                         dimethylcycloprop
                         anecarboxylate
                         (Permethrin) (CAS
                         No. 52645-53-1)
                         (provided for in
                         subheading
                         2916.20.50)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
Case 1:03-cv-00734-MEF-SRW Document 12 Filed 10/15/2003 Page 1 of 1
Unassociated Document


    


    


    
      
        	
                nwbo
      corporation & bob duane & cary hise,

              	 
      	
                primesource
      mortgage, inc.

              
	
                individually

              	 
      	
                1112
      n. main street

              
	
                3230
      camp bowie, suite a

              	 
      	
                roswell,
      nm 88201

              
	
                fort
      worth, tx 76107

              	 
      	 
      
	 
      	 
      	 
      
	
                borrower’s
      name and address

              	 
      	
                lender’s
      name and address

              


      

    

    


    For value
received, I promise to pay to you, or your order, at your address listed above
the principal
sum of ninety
eight thousand nine hundred fifty four dollars and 18/100 Dollars  $98,954.18.

    


    x Single Advance:  I
will receive all of this principle sum on 05/15/2007.  No additional
advances are contemplated under this note.

    


    interest: 
I agree to pay interest on the outstanding principal balance from 05/30/2008 at
the rate of 9.250% per year until 08/30/2009.

    


    accrual
method: Interest will be calculated on a ACTUAL/360 basis.

    


    post
maturity rate: I agree to pay interest on the unpaid balance of this note
owing after maturity, and until paid in full, as stated below:

    


    
      	
               
      

            	
              x

            	
              on
      the same fixed or variable rate basis in effect before maturity (as
      indicated above).

            


    

    


    payments:
I agree to pay this note as follows:

    


    14
monthly interest payments of $1,000.00 each beginning 06-30-08 and 1 payment of
$96,381.53 on 08/30/09.

    


    x security:
This note is separately secured by (described separate document by type and
date):

    


    security
agreement dated February 16, 2007 and November 16, 2006.

    


    signatures:  I agree
to the terms of this note.

    


    Signature
for Lender

    


    
      
        
          
            
              
                
                  	
                          primesource
      mortgage, inc.

                        	 
      	
                          nwbo
      corporation & bob duane &
      cary hise, individually

                        
	 
      	 
      	
                           

                        
	
                          /s/ Jeffrey R. Smith

                        	 
      	
                          /s/ Bob Duane, President &
      Individually

                        
	 
      	 
      	 
      
	 
      	 
      	
                          /s/ Cary Hise,
  Individually
IN THE UNITED STATES DISTRICT COURT FOR THE

MIDDLE DISTRICT OF ALABAMA

SOUTHERN DIVISION

UNITED STATES OF AMERICA )

)

V. ) CASE NO: 1:06-cr-185-DRB

)

BOBBY R. HARDRICK, II )

NOTICE OF INTENT TO CHANGE PLEA

COMES NOW the Defendant, Bobby R. Hardrick, II, by and through undersigned counsel,

Donnie W. Bethel, and notifies the Court of his intent to change his previously entered plea of not

guilty to guilty. Defendant waives his right to plea in front of a district judge and consents to do so

before a magistrate judge.

Dated this 5 day of October, 2006. th

Respectfully submitted,

s/ Donnie W. Bethel

DONNIE W. BETHEL

Assistant Federal Defender

201 Monroe Street, Suite 407

Montgomery, Alabama 36104

Phone: (334) 834-2099

Fax: (334) 834-0353

E-mail:don_bethel@fd.org

IN Bar Code: 14773-49

Case 1:06-cr-00185-CSC Document 10 Filed 10/05/2006 Page 1 of 2
IN THE UNITED STATES DISTRICT COURT FOR THE

MIDDLE DISTRICT OF ALABAMA

SOUTHERN DIVISION

UNITED STATES OF AMERICA )

)

V. ) CASE NO: 1:06-cr-185-DRB

)

BOBBY R. HARDRICK, II )

CERTIFICATE OF SERVICE

I hereby certify that on October 5, 2006, I electronically filed the foregoing with the Clerk

of Court using the CM/ECF system which will send notification of such filing to the following: 

Kent B. Brunson

Assistant United States Attorney

One Court Square, Suite 201

Montgomery, Alabama 36104

Nathan T. Golden

Department of the Army

Office of Staff Judge Advocate

Military Justice

Building 5700, Novosel Street

Ft. Rucker, Alabama 36362

Respectfully submitted,

s/ Donnie W. Bethel

DONNIE W. BETHEL

Assistant Federal Defender

201 Monroe Street, Suite 407

Montgomery, Alabama 36104

Phone: (334) 834-2099

Fax: (334) 834-0353

E-mail:don_bethel@fd.org

IN Bar Code: 14773-49

Case 1:06-cr-00185-CSC Document 10 Filed 10/05/2006 Page 2 of 2